Working in the Inflammasome Lab has been a great experience. It is a fantastic team of people, passionate about their research, very supportive and generous in sharing their expertise.
Office Telephone: +61 7 3346 2351
Other Telephone: +61 7 3346 2356
AWARDS, GRANTS AND PRIZES
2012 International Postgraduate Research Scholarship
2012 University of Queensland Centennial Scholarship
2010 MSc in Biochemistry/Molecular Biology, Taras Shevchenko National University of Kyiv, Ukraine
2008 BSc in Biology, Taras Shevchenko National University of Kyiv, Ukraine
ORIGINAL RESEARCH ARTICLES
Sester DP, Zamoshnikova A, Thygesen SJ, Vajjhala PR, Cridland SO, Schroder K, Stacey KJ. (2016).
Assessment of inflammasome formation by flow cytometry. Current Protocols In press.
Zamoshnikova A, Groß CJ, Schuster S, Chen KW, Wilson A, Tacchini-Cottier F, Schroder K (2016).
NLRP12 is a neutrophil-specific, negative regulator of in vitro cell migration but does not modulate LPS- or infection-induced NF-κB or ERK signalling. Immunobiology 221(2):341-6. Pubmed
Schroder K, Sagulenko V, Zamoshnikova A, Richards AA, Cridland JA, Irvine KM, Stacey KJ, Sweet MJ (2012).
Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology 217: 1325-1329. Pubmed
REVIEWS AND BOOK CHAPTERS
Chen KW, Richards AA, Zamoshnikova A, Schroder K (2014).
Inflammasomes and inflammation. Chapter 8 in Cancer and Inflammation Mechanisms, Y. Hiraku, S. Kawanishi, H. Ohshima (Editors). (USA: John Wiley and Sons, Inc). Wiley
Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LV (2011).
FCRL6 receptor: expression and associated proteins. Immunology Letters 34(2):174-82.
Yurchenko M, Shlapatska LM, Romanets OL, Ganshevskiy D, Kashuba E, Zamoshnikova A, Ushenin YV, Snopok BA, Sidorenko SP (2011).
CD150-mediated Akt signalling pathway in normal and malignant B cells. Experimental Oncology 33(1):9-18.
Copyright © 2017 - The University of Queensland